An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of 91.2 per cent in its listed subsidiary GSK Egypt. Photo: Salah Malkawi / The National
An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of 91.2 per cent in its listed subsidiary GSK Egypt. Photo: Salah Malkawi / The National
An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of 91.2 per cent in its listed subsidiary GSK Egypt. Photo: Salah Malkawi / The National
An employee works in the lab of Hikma Pharmaceuticals in Amman, Jordan. The British drugmaker said it has signed a non-binding agreement with Glaxo Group for the potential sale of its entire stake of

Hikma in talks to buy GlaxoSmithKline’s Egypt subsidiary


Deepthi Nair
  • English
  • Arabic

Hikma Pharmaceuticals said it plans to buy GlaxoSmithKline’s stake in some Middle East assets, including its pharmaceutical, consumer commercialisation and manufacturing businesses in Egypt and its drugs business in Tunisia. The acquisition is expected to create the largest pharmaceuticals company in Egypt.

The drugmaker, which was founded in Jordan and is listed on the London Stock Exchange, signed a non-binding agreement with Glaxo Group for the potential purchase of its 91.2 per cent stake in its GSK Egypt subisidiary, according to a statement on Tuesday. The transaction will be carried out by submitting a mandatory tender offer for 100 per cent of GSK company's shares.

The deal will also be subject to the completion of due diligence and regulatory approvals. The timeline and the potential value for the acquisition are yet to be disclosed.

The potential acquisition comes amid the worsening Covid-19 pandemic that has put unprecedented pressure on regional and global healthcare systems. The pandemic has led to the rapid acceleration of efforts to find solutions in the areas of diagnostics and pharmaceuticals.

The biggest market for Hikma, which produces and markets a wide range of branded and non-branded generic medicines, is the US, followed by Saudi Arabia and Egypt. Revenue for the first six months of 2020 increased by 8 per cent to $1.1bn and net profit rose 16 per cent to $212 million.

With annual revenues of about 4 billion Egyptian pounds ($254.4m), GSK Egypt has a 5 per cent share of the local pharma production market, according to a research note from investment house Naeem Brokerage. It added that the company sells more than 160 million units per annum in Egypt.

“Hikma Egypt is roughly half the size of GSK with a market share of 2.6 per cent on a year-to-date basis in 2020,” the note said.

The transaction, if successful, will create the biggest pharma producer in Egypt with a combined market share of close to 7.5 per cent in terms of sales value. This will make it larger than Novartis (with a market share of 6.7 per cent) and Sanofi (5.3 per cent).

Naeem Holdings' analysts estimated that GSK’s Egyptian operations, excluding its Tunisia business, could be valued at between $600m to $650m.

Key facilities
  • Olympic-size swimming pool with a split bulkhead for multi-use configurations, including water polo and 50m/25m training lanes
  • Premier League-standard football pitch
  • 400m Olympic running track
  • NBA-spec basketball court with auditorium
  • 600-seat auditorium
  • Spaces for historical and cultural exploration
  • An elevated football field that doubles as a helipad
  • Specialist robotics and science laboratories
  • AR and VR-enabled learning centres
  • Disruption Lab and Research Centre for developing entrepreneurial skills
Company%20profile
%3Cp%3E%3Cstrong%3EName%3A%3C%2Fstrong%3E%20WallyGPT%3Cbr%3E%3Cstrong%3EStarted%3A%20%3C%2Fstrong%3E2014%3Cbr%3E%3Cstrong%3EFounders%3A%20%3C%2Fstrong%3ESaeid%20and%20Sami%20Hejazi%3Cbr%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Dubai%3Cbr%3E%3Cstrong%3ESector%3A%20%3C%2Fstrong%3EFinTech%3Cbr%3E%3Cstrong%3EInvestment%20raised%3A%20%3C%2Fstrong%3E%247.1%20million%3Cbr%3E%3Cstrong%3ENumber%20of%20staff%3A%3C%2Fstrong%3E%2020%3Cbr%3E%3Cstrong%3EInvestment%20stage%3A%20%3C%2Fstrong%3EPre-seed%20round%3C%2Fp%3E%0A
The specs

Engine: 4.0-litre V8 twin-turbocharged and three electric motors

Power: Combined output 920hp

Torque: 730Nm at 4,000-7,000rpm

Transmission: 8-speed dual-clutch automatic

Fuel consumption: 11.2L/100km

On sale: Now, deliveries expected later in 2025

Price: expected to start at Dh1,432,000

%3Cp%3E%3Cstrong%3EDirector%3A%3C%2Fstrong%3E%20Nag%20Ashwin%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStarring%3A%20%3C%2Fstrong%3EPrabhas%2C%20Saswata%20Chatterjee%2C%20Deepika%20Padukone%2C%20Amitabh%20Bachchan%2C%20Shobhana%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ERating%3A%20%3C%2Fstrong%3E%E2%98%85%E2%98%85%E2%98%85%E2%98%85%3C%2Fp%3E%0A
While you're here
Ferrari 12Cilindri specs

Engine: naturally aspirated 6.5-liter V12

Power: 819hp

Torque: 678Nm at 7,250rpm

Price: From Dh1,700,000

Available: Now

Directed by Sam Mendes

Starring Dean-Charles Chapman, George MacKay, Daniel Mays

4.5/5

UAE currency: the story behind the money in your pockets
ESSENTIALS

The flights 
Fly Etihad or Emirates from the UAE to Moscow from 2,763 return per person return including taxes. 
Where to stay 
Trips on the Golden Eagle Trans-Siberian cost from US$16,995 (Dh62,414) per person, based on two sharing.

Company Profile

Name: Thndr
Started: 2019
Co-founders: Ahmad Hammouda and Seif Amr
Sector: FinTech
Headquarters: Egypt
UAE base: Hub71, Abu Dhabi
Current number of staff: More than 150
Funds raised: $22 million

World ranking (at month’s end)
Jan - 257
Feb - 198
Mar - 159
Apr - 161
May - 159
Jun – 162
Currently: 88

Year-end rank since turning pro
2016 - 279
2015 - 185
2014 - 143
2013 - 63
2012 - 384
2011 - 883

Brave CF 27 fight card

Welterweight:
Abdoul Abdouraguimov (champion, FRA) v Jarrah Al Selawe (JOR)

Lightweight:
Anas Siraj Mounir (TUN) v Alex Martinez (CAN)

Welterweight:
Mzwandile Hlongwa (RSA) v Khamzat Chimaev (SWE)

Middleweight:
Tarek Suleiman (SYR) v Rustam Chsiev (RUS)
Mohammad Fakhreddine (LEB) v Christofer Silva (BRA)

Super lightweight:
Alex Nacfur (BRA) v Dwight Brooks (USA)

Bantamweight:
Jalal Al Daaja (JOR) v Tariq Ismail (CAN)
Chris Corton (PHI) v Zia Mashwani (PAK)

Featherweight:
Sulaiman (KUW) v Abdullatip (RUS)

Super lightweight:
Flavio Serafin (BRA) v Mohammad Al Katib (JOR)

UAE currency: the story behind the money in your pockets
Sri Lanka Test squad:

Dimuth Karunaratne (stand-in captain), Niroshan Dickwella (vice captain), Lahiru Thirimanne, Kaushal Silva, Kusal Mendis, Kusal Janith Perera, Milinda Siriwardana, Dhananjaya de Silva, Oshada Fernando, Angelo Perera, Suranga Lakmal, Kasun Rajitha, Vishwa Fernando, Chamika Karunaratne, Mohamed Shiraz, Lakshan Sandakan and Lasith Embuldeniya.

The biog

Siblings: five brothers and one sister

Education: Bachelors in Political Science at the University of Minnesota

Interests: Swimming, tennis and the gym

Favourite place: UAE

Favourite packet food on the trip: pasta primavera

What he did to pass the time during the trip: listen to audio books

Wenger's Arsenal reign in numbers

1,228 - games at the helm, ahead of Sunday's Premier League fixture against West Ham United.
704 - wins to date as Arsenal manager.
3 - Premier League title wins, the last during an unbeaten Invincibles campaign of 2003/04.
1,549 - goals scored in Premier League matches by Wenger's teams.
10 - major trophies won.
473 - Premier League victories.
7 - FA Cup triumphs, with three of those having come the last four seasons.
151 - Premier League losses.
21 - full seasons in charge.
49 - games unbeaten in the Premier League from May 2003 to October 2004.

UAE currency: the story behind the money in your pockets
Tamkeen's offering
  • Option 1: 70% in year 1, 50% in year 2, 30% in year 3
  • Option 2: 50% across three years
  • Option 3: 30% across five years 
Ireland (15-1):

Ireland (15-1): Rob Kearney; Keith Earls, Chris Farrell, Bundee Aki, Jacob Stockdale; Jonathan Sexton, Conor Murray; Jack Conan, Sean O'Brien, Peter O'Mahony; James Ryan, Quinn Roux; Tadhg Furlong, Rory Best (capt), Cian Healy

Replacements: Sean Cronin, Dave Kilcoyne, Andrew Porter, Ultan Dillane, Josh van der Flier, John Cooney, Joey Carbery, Jordan Larmour

Coach: Joe Schmidt (NZL)